SAREX
Price
$12.57
Change
-$0.03 (-0.24%)
Updated
Sep 20 closing price
VGSNX
Price
$21.46
Change
-$0.07 (-0.33%)
Updated
Sep 20 closing price
Ad is loading...

SAREX vs VGSNX

Header iconSAREX vs VGSNX Comparison
Open Charts SAREX vs VGSNXBanner chart's image
SA Real Estate Securities
Price$12.57
Change-$0.03 (-0.24%)
VolumeN/A
CapitalizationN/A
Vanguard Real Estate Index Institutional
Price$21.46
Change-$0.07 (-0.33%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
SAREX vs VGSNX Comparison Chart
Loading...
VS
SAREX vs. VGSNX commentary
Sep 21, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SAREX is a StrongSell and VGSNX is a StrongSell.

FUNDAMENTALS
Fundamentals
VGSNX has more cash in the bank: 70.5B vs. SAREX (141M). VGSNX pays higher dividends than SAREX: VGSNX (4.01) vs SAREX (2.75). SAREX was incepted earlier than VGSNX: SAREX (17 years) vs VGSNX (21 years). VGSNX is a more actively managed with annual turnover of: 9.00 vs. SAREX (2.00). SAREX has a lower initial minimum investment than VGSNX: SAREX (100000) vs VGSNX (5000000). VGSNX (30.91) and SAREX (30.48) have marching annual gain over last year. VGSNX return over 5 years is better than : 26.49 vs. SAREX (3.56).
SAREXVGSNXSAREX / VGSNX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence17 years21 years-
Gain YTD13.55013.136103%
Front LoadN/AN/A-
Min. Initial Investment10000050000002%
Min. Initial Investment IRAN/AN/A-
Net Assets141M70.5B0%
Annual Yield % from dividends2.754.0169%
Returns for 1 year30.4830.9199%
Returns for 3 years-8.543.89-220%
Returns for 5 years3.5626.4913%
Returns for 10 years60.5989.8667%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
APGE58.385.43
+10.25%
Apogee Therapeutics
AEI1.230.02
+1.28%
Alset
VTOL36.00-0.43
-1.18%
Bristow Group
TRMB58.58-1.62
-2.69%
Trimble
LFCR5.00-0.62
-11.03%
Lifecore Biomedical